非小细胞肺癌患者转移性淋巴结中18F-FDG流入速率常数升高
本研究对62例非小细胞肺癌患者行动态18F-FDG PET扫描,比较原发肿瘤与转移性淋巴结的Patlak图形分析Ki与常规SUV。结果显示转移性淋巴结的Ki在M1组显著高于M0组,而SUV在两组间无显著差异;作者认为动态建模对转移性淋巴结的检测比静态分析更敏感。
要点
- 转移性淋巴结Ki在M1组显著高于M0组,而SUV在两组间无显著差异
- 原发肿瘤的Ki与SUV在M1组均显著高于M0组
- 原发肿瘤SUV与Ki在鳞癌中显著高于腺癌,EGFR突变型与野生型间无显著差异
核心结论
- 转移性淋巴结的动态建模Ki分析比静态SUV分析对非小细胞肺癌转移性淋巴结的检测更敏感,而两种方法对原发肿瘤均敏感。
- 作者认为这种无创影像方法可能成为无法进行组织学检查患者评估转移性淋巴结和原发肿瘤状态的重要工具。
研究设计与样本
- 对76例肺癌患者行动态18F-FDG PET扫描,最终纳入62例非小细胞肺癌病例。
- 37例为初诊早期和局部晚期无远处转移的肺癌患者(M0组),25例为转移性肺癌患者(M1组)。
- 基于动态建模进行Patlak图形分析计算Ki,并从常规静态数据获取SUV进行分析。
- 临床试验注册号为NCT03679936。
主要发现
- 原发肿瘤:M1组KiPT为0.050 ± 0.005 min-1 vs M0组0.026 ± 0.004 min-1(p < 0.001),M1组SUVPT为8.41 ± 0.64 vs M0组5.23 ± 0.73(p < 0.01),M1组均显著高于M0组。
- 转移性淋巴结:M1组KiMLN为0.033 ± 0.005 min-1 vs M0组0.016 ± 0.003 min-1(p < 0.01),M1组显著高于M0组。
- 转移性淋巴结:M0组SUVMLN为4.22 ± 0.49 vs M1组5.57 ± 0.59(p > 0.05),两组间无显著差异。
- 原发肿瘤的SUVPT和KiPT在鳞状细胞癌中均显著高于腺癌,但在EGFR突变型与野生型之间均无显著差异。
- 不同组间SUV与Ki的总体Spearman分析显示相关性不一(r = 0.46-0.94)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Primary tumor (PT) and metastatic lymph node (MLN) status have a great influence on diagnosis and treatment of lung cancer. Our main purpose was to investigate the imaging characteristics of PT or MLN by applying the 18F-FDG PET dynamic modeling approach for non-small cell lung cancer (NSCLC). METHODS: Dynamic 18F-FDG PET scans were performed for 76 lung cancer patients, and 62 NSCLC cases were finally included in this study: 37 with newly diagnosed early and locally advanced lung cancer without distant metastases (group M0) and 25 metastatic lung cancer (group M1). Patlak graphic analysis (Ki calculation) based on the dynamic modeling and SUV analysis from conventional static data were performed. RESULTS: For PT, both KiPT (0.050 ± 0.005 vs 0.026 ± 0.004 min-1, p < 0.001) and SUVPT (8.41 ± 0.64 vs 5.23 ± 0.73, p < 0.01) showed significant higher values in group M1 than M0. For MLN, KiMLN showed significant higher values in M1 than M0 (0.033 ± 0.005 vs 0.016 ± 0.003 min-1, p < 0.01), while no significant differences were found for SUVMLN between M0 and M1 (4.22 ± 0.49 vs 5.57 ± 0.59, p > 0.05). Both SUV PT and KiPT showed significant high values in squamous cell carcinoma than adenocarcinoma, but neither SUVPT nor KiPT showed significant differences between EGFR mutants versus wild types. The overall Spearman analysis for SUV and Ki from different groups showed variable correlation (r = 0.46-0.94). CONCLUSION: The dynamic modeling for MLN (KiMLN) showed more sensitive than the static analysis (SUV) to detect metastatic lymph nodes in NSCLC, although both methods were sensitive for PT. This methodology of non-invasive imaging may become an important tool to evaluate MLN and PT status for patients who cannot undergo histological examination. CLINICAL TRIAL REGISTRATION: The clinical trial registration number is NCT03679936 (http://www.clinicaltrials.gov/).
引用
- Yang M, Lin Z, Xu Z, et al. Influx rate constant of 18F-FDG increases in metastatic lymph nodes of non-small cell lung cancer patients. Eur J Nucl Med Mol Imaging. 2020. PMID: 31974680. doi:10.1007/s00259-020-04682-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。